Acropolis Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77M Sell
13,768
-875
-6% -$102K 0.07% 90
2026
Q1
$1.76M Sell
14,643
-406
-3% -$46.9K 0.08% 83
2025
Q4
$1.58M Sell
15,049
-744
-5% -$69.8K 0.07% 89
2025
Q3
$1.25M Buy
15,793
+750
+5% +$61.8K 0.06% 101
2025
Q2
$1.19M Sell
15,043
-1,562
-9% -$124K 0.07% 90
2025
Q1
$1.49M Sell
16,605
-591
-3% -$55.2K 0.09% 84
2024
Q4
$1.71M Sell
17,196
-762
-4% -$78.6K 0.1% 76
2024
Q3
$2.04M Sell
17,958
-307
-2% -$36.5K 0.12% 64
2024
Q2
$2.26M Buy
18,265
+1,621
+10% +$209K 0.14% 58
2024
Q1
$2.2M Buy
16,644
+15
+0.1% +$1.85K 0.14% 60
2023
Q4
$1.81M Sell
16,629
-762
-4% -$79.1K 0.13% 63
2023
Q3
$1.79M Sell
17,391
-31
-0.2% -$3.34K 0.14% 61
2023
Q2
$2.01M Sell
17,422
-156
-0.9% -$17.7K 0.16% 61
2023
Q1
$1.87M Buy
17,578
+454
+3% +$49K 0.15% 61
2022
Q4
$1.9M Buy
+17,124
New +$1.75M 0.17% 52

Other funds holding MRK

Acropolis Investment Management's MRK Position: Q2 2026 in Review

Acropolis Investment Management reduced its Merck (MRK) stake by 6% in Q2 2026, selling an estimated $102K and leaving 13,768 shares worth $1.77M. The position accounts for 0.07% of the portfolio, ranked #90.

Acropolis Investment Management first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.26M in Q2 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Acropolis Investment Management held 13,768 shares of Merck worth $1.77M as of Q2 2026.
  • Acropolis Investment Management sold 875 Merck shares in Q2 2026, an estimated $102K.
  • Merck made up 0.07% of Acropolis Investment Management's portfolio in Q2 2026, its #90 holding.
  • Acropolis Investment Management first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Acropolis Investment Management's Merck position peaked at $2.26M in Q2 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Acropolis Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.